SHH and sarcoma: Further association with mutations of the BCL6 repressor gene BCOR, commonly altered in medulloblastomas, neuroepithelial tumors, and sarcomas, highlights a further avenue for interventional study through its regulation of the SHH pathway (Tiberi et al., 2014).